CN Patent

CN106061506A — 包含抗精神病药物和vmat2抑制剂的药物组合物及其用途

Assigned to Neurocrine Biosciences Inc · Expires 2016-10-26 · 10y expired

What this patent protects

本文提供了通过向有需要的对象施用包含抗精神病化合物和VMAT2抑制剂的药物组合物来治疗精神分裂症和分裂情感性障碍的新方法。

USPTO Abstract

本文提供了通过向有需要的对象施用包含抗精神病化合物和VMAT2抑制剂的药物组合物来治疗精神分裂症和分裂情感性障碍的新方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN106061506A
Jurisdiction
CN
Classification
—
Expires
2016-10-26
Drug substance claim
No
Drug product claim
No
Assignee
Neurocrine Biosciences Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.